Industry News
The latest medical device regulatory news, clinical trials, and market insights
Regulatory Update EEG Guided Binaural Beat Audio Trial Aims to Reduce Stress and Enhance Cognition
This regulatory update summarizes a Texas Tech led trial testing EEG guided binaural beat audio to reduce performance related stress…
Regulatory Watch: Transcutaneous Vagus Nerve Stimulation in Diabetic Polyneuropathy Trials Targets Pain Reduction and Functional Outcomes
A new trial from Cairo University investigates transcutaneous vagus nerve stimulation for diabetic polyneuropathy, focusing on pain intensity, nerve conduction…
Regulatory Focus on Wrist Based Strength Band Platform for Acute Opioid Dosing Detection
Meta description: A wrist worn Strength Band Platform is studied to detect acute opioid dosing events and measure withdrawal using…
Regulatory Update: Cairo University Initiates Laser Acupuncture Study for Carpal Tunnel in Breast Cancer Patients
Meta description: A new clinical trials entry registers laser acupuncture for carpal tunnel symptoms in breast cancer patients, signaling regulatory…
Supira System Study in Complex High Risk PCI Advances Safety and Performance Focus Under Regulatory Watch
Meta description: A regulatory update on the Supira System trial in complex high risk PCI under way at Supira Medical,…
Shockfast Intravascular Lithotripsy Device for Calcified Coronary Lesions: Regulatory Update on Trial Activity and Sponsor Details
Published February 13, 2026. This regulatory update reports on the Shockwave IVL and Shockfast IVL devices for calcified coronary lesions…
Swissmedic Announces Archiving of Analgesic Medicinal Product Information Sheets
Published: 2026-02-11 Regulatory teams and medical device professionals should note the upcoming archiving of information sheets on specimen texts for…
Swissmedic Updates Guidance Document and Signal Notification Form for Drug Safety Signals
As of February 11, 2026, Swissmedic has comprehensively revised the Guidance document Drug Safety Signals HMP, modifying its structure and…
Swissmedic Updates Annex 7: Revised List of Variations Now in Effect
As of 1 February 2026, a revised list of variations according to Articles 21-24 of the Swiss Therapeutic Products Ordinance…
Safety Risks in Medical Device Treatments for Wrinkle Correction (‘Fillers’)
Meta Description: Swissmedic reports significant non-conformities in wrinkle treatment using medical devices. Published: 2026-02-11 Swissmedic’s recent focus campaign on therapeutic…
Temporary Permit for Distribution of Nemluvio Powder and Solvent for Solution for Injection in a Pre-filled Pen
Temporary authorization for distribution in German packaging A recent announcement by Swissmedic highlights a significant development in the distribution of…
Recall of Similasan Schlafstörungen Globuli Due to Quality Issues: Regulatory Implications for Swiss Market
As of February 11, 2026, Swissmedic announced a recall of Similasan Schlafstörungen Globuli due to quality issues affecting the product’s…